Patricia E López-Correa1,2, Leonardo S Lino-Silva3,4, Armando Gamboa-Domínguez5, César Zepeda-Najar6, Rosa A Salcedo-Hernández7. 1. Surgical pathology, Instituto Nacional de Cancerología, Mexico City, Mexico. 2. Surgical pathology, Fundación Universitaria de Ciencias de la Salud (FUCS), Hospital de San José, Bogotá, Colombia. 3. Surgical pathology, Instituto Nacional de Cancerología, Mexico City, Mexico. saul.lino.sil@gmail.com. 4. Gastrointestinal Pathology Division, Instituto Nacional de Cancerología de México (Mexico's National Cancer Institute), Av. San Fernando # 22, Sección XVI, Tlalpan, CP 14080, Mexico City, Mexico. saul.lino.sil@gmail.com. 5. Surgical Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. 6. Surgical Oncology, Hospital Ángeles Tijuana, Tijuana, Baja California Norte, Mexico. 7. Surgical oncology, Instituto Nacional de Cancerología, Mexico City, Mexico.
Abstract
BACKGROUND: The frequency of colorectal cancer (CRC) with defective mismatch repair (dMMR) is estimated between 5 and 15%. In our population, the frequency of dMMR is unknown. Our objective was to show the frequency of dMMR. METHODS: Determination of dMMR with immunohistochemistry was performed prospectively for 202 patients who presented consecutively with CRC for the first time at our institution. RESULTS: The median age was 59 years (IQR 47 to 68), 119 (58.9%) were women, and 43 (21.3%) cases showed dMMR. The only clinicopathological characteristics associated with dMMR were the location in the right colon and the presence of a family history of cancer. In the multivariate analysis, only the presence of the tumor in the right colon was associated with dMMR (OR = 5.823, 95%-C.I. = 2.653-12.784, p < .001). CONCLUSION: The 21.3% of the cases demonstrated a dMMR and the only clinical-pathological characteristic associated with dMMR was location in the right colon.
BACKGROUND: The frequency of colorectal cancer (CRC) with defective mismatch repair (dMMR) is estimated between 5 and 15%. In our population, the frequency of dMMR is unknown. Our objective was to show the frequency of dMMR. METHODS: Determination of dMMR with immunohistochemistry was performed prospectively for 202 patients who presented consecutively with CRC for the first time at our institution. RESULTS: The median age was 59 years (IQR 47 to 68), 119 (58.9%) were women, and 43 (21.3%) cases showed dMMR. The only clinicopathological characteristics associated with dMMR were the location in the right colon and the presence of a family history of cancer. In the multivariate analysis, only the presence of the tumor in the right colon was associated with dMMR (OR = 5.823, 95%-C.I. = 2.653-12.784, p < .001). CONCLUSION: The 21.3% of the cases demonstrated a dMMR and the only clinical-pathological characteristic associated with dMMR was location in the right colon.
Authors: Yenny Montenegro; José Luis Ramírez-Castro; Luis Fernando Isaza; Gabriel Bedoya; Carlos Mario Muñetón-Peña Journal: Rev Med Chil Date: 2006-12-13 Impact factor: 0.553
Authors: C M Egoavil; P Montenegro; J L Soto; L Casanova; J Sanchez-Lihon; M I Castillejo; A Martinez-Canto; L Perez-Carbonell; A Castillejo; C Guarinos; V M Barbera; R Jover; A Paya; C Alenda Journal: Pathology Date: 2011-04 Impact factor: 5.306
Authors: Samir Gupta; Raheela Ashfaq; Payal Kapur; Bianca B Afonso; Thuy-Phuong T Nguyen; Faryal Ansari; C Richard Boland; Ajay Goel; Don C Rockey Journal: Cancer Date: 2010-11-01 Impact factor: 6.860
Authors: Christine M Ribic; Daniel J Sargent; Malcolm J Moore; Stephen N Thibodeau; Amy J French; Richard M Goldberg; Stanley R Hamilton; Pierre Laurent-Puig; Robert Gryfe; Lois E Shepherd; Dongsheng Tu; Mark Redston; Steven Gallinger Journal: N Engl J Med Date: 2003-07-17 Impact factor: 91.245
Authors: Carlos A Vaccaro; Jorge E Carrozzo; Esteban Mocetti; Mariana Berho; Paula Valdemoros; Eduardo Mullen; Myriam Oviedo; Maria A Redal Journal: Medicina (B Aires) Date: 2007 Impact factor: 0.653
Authors: James H Park; Arfon G Powell; Campbell S D Roxburgh; Paul G Horgan; Donald C McMillan; Joanne Edwards Journal: Br J Cancer Date: 2016-02-09 Impact factor: 7.640